Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0531
-0.0069 (-11.50%)
Sep 8, 2026, 3:54 PM EST
PVCT Market Cap
PVCT has a market cap or net worth of $22.32 million as of September 8, 2026. Its market cap has decreased by -27.90% in one year.
Market Cap
22.32M
Enterprise Value
24.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
ChartMarket Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 22.32M, an increase of 516,254.97%. That is a compound annual growth rate of 41.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 22.32M | -5.01% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 35.87M |
| Cell Source | 35.13M |
| Vicapsys Life Sciences | 32.37M |
| ProText Mobility | 30.77M |
| Biomind Labs | 19.42M |
| EOM Pharmaceuticals Holdings | 19.11M |
| Finch Therapeutics Group | 16.62M |
| ZIVO Bioscience | 14.95M |